 VICTORIA, British Columbia--BUSINESS WIRE--Aurinia Pharmaceuticals Inc. NASDAQ: AUPH Aurinia or the Company announces a change to the dial-in numbers for the upcoming first quarter financial and operational results announcement on Tuesday, May 10, 2022. The new numbers for interested participants to dial in are: 866 682-6100 862 298-0702 Toll-free U.S. Canada. The audio webcast can also be accessed under NewsEvents through the Investors section of the Aurinia corp 